Who has invested in CapsoVision?

No investors are named on the public record for CapsoVision yet.

CapsoVision Funding: $118M Raised, Series E (2020)

CapsoVision funding overview

CapsoVision is a Biotech company based in Saratoga, California. CapsoVision has raised $118M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in May 2020. The round record for CapsoVision runs through 2020; nothing later has been disclosed.

CapsoVision at a glance

Total raised: $118M
Latest round: Series E
Latest round date: May 2020
Industry: Biotech
Headquarters: Saratoga, California

Frequently asked about CapsoVision funding

How much has CapsoVision raised?: CapsoVision has raised $118M in total disclosed funding across the rounds on record.
Who has invested in CapsoVision?: No investors are named on the public record for CapsoVision yet.
What was the latest CapsoVision funding round?: The most recent disclosed round is a Series E, announced in May 2020.
Where is CapsoVision based?: CapsoVision is based in Saratoga, California.
What sector does CapsoVision operate in?: CapsoVision is tracked under Biotech from Saratoga, California, with $118M in disclosed funding.
When did CapsoVision last raise?: The last disclosed CapsoVision round closed in May 2020 at Series E.

CapsoVision totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Saratoga below to benchmark round size and investor mix.

CapsoVision Funding: $118M Raised, Series E (2020)

CapsoVision funding overview

CapsoVision at a glance

Frequently asked about CapsoVision funding

Companies related to CapsoVision (26)

Browse related funding lists (3)